KWAR23 is a monoclonal antibody targeting SIRPalpha that blocks the interaction of SIRPalpha and SIRPgamma with CD47, impairing chronic T-cell activation and IFN-gamma secretion.
Molecular Weight:
145.5
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
